Callan Family Office LLC acquired a new stake in MKS Inc. (NASDAQ:MKSI – Free Report) during the second quarter, HoldingsChannel reports. The firm acquired 4,093 shares of the scientific and technical instruments company’s stock, valued at approximately $1,821,000.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Keating Financial Advisory Services Inc. purchased a new position in shares of MKS during the second quarter worth about $25,000. Bowie Capital Management LLC acquired a new position in MKS in the 2nd quarter valued at about $18,970,000. Allworth Financial LP purchased a new stake in MKS during the 2nd quarter valued at approximately $624,000. Greenspring Advisors LLC purchased a new stake in MKS during the 2nd quarter valued at approximately $215,000. Finally, NFJ Investment Group LLC acquired a new stake in MKS during the 2nd quarter worth approximately $16,323,000. 99.79% of the stock is owned by hedge funds and other institutional investors.
MKS Price Performance
Shares of MKSI opened at $279.11 on Monday. The company has a current ratio of 1.14, a quick ratio of 0.72 and a debt-to-equity ratio of 0.85. The stock’s 50 day moving average is $341.95 and its two-hundred day moving average is $294.68. MKS Inc. has a twelve month low of $97.50 and a twelve month high of $447.62. The firm has a market capitalization of $18.87 billion, a PE ratio of 44.52, a P/E/G ratio of 0.59 and a beta of 1.98.
MKS Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Tuesday, August 25th will be given a $0.25 dividend. The ex-dividend date is Tuesday, August 25th. This represents a $1.00 annualized dividend and a yield of 0.4%. MKS’s dividend payout ratio is presently 15.95%.
Insider Buying and Selling
In other news, CEO John Tseng-Chung Lee sold 10,000 shares of the company’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $302.01, for a total transaction of $3,020,100.00. Following the transaction, the chief executive officer directly owned 134,776 shares of the company’s stock, valued at $40,703,699.76. This represents a 6.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Joseph B. Donahue sold 2,100 shares of the stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $327.95, for a total transaction of $688,695.00. Following the completion of the transaction, the director owned 10,033 shares of the company’s stock, valued at $3,290,322.35. This represents a 17.31% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 37,491 shares of company stock valued at $12,102,072 in the last quarter. Corporate insiders own 0.57% of the company’s stock.
Wall Street Analysts Forecast Growth
MKSI has been the topic of several analyst reports. BMO Capital Markets assumed coverage on MKS in a research note on Tuesday, June 30th. They issued an “outperform” rating and a $453.00 target price on the stock. The Goldman Sachs Group restated a “sell” rating and set a $265.00 price target on shares of MKS in a research note on Thursday, May 7th. Deutsche Bank Aktiengesellschaft set a $360.00 price target on MKS in a report on Friday, July 31st. JPMorgan Chase & Co. lifted their price objective on shares of MKS from $365.00 to $380.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Finally, Mizuho set a $360.00 price objective on shares of MKS in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $385.00.
View Our Latest Stock Report on MKS
MKS Company Profile
MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.
The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.
See Also
- Five stocks we like better than MKS
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MKSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MKS Inc. (NASDAQ:MKSI – Free Report).
Receive News & Ratings for MKS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS and related companies with MarketBeat.com's FREE daily email newsletter.
